Prevalence pattern of multidrug resistant Proteus mirabilis recovered from wound of human and cats in Wasit governorate
1 Alqasaim Qreen University Iraq, Babylon, Iraq.
2 Babylon university Iraq, Babylon, Iraq.
3 Alqadisiyah University, Alqadisiyah. Iraq.
4 Ministry of Education, Wasit Education Directorate, wasit, Iraq.
5 Alkut University College, wasit, Iraq.
Research Article
World Journal of Advanced Research and Reviews, 2023, 17(02), 453–459
Article DOI: 10.30574/wjarr.2023.17.2.0203
Publication history:
Received on 20 December 2022; revised on 01 Februay 2023; accepted on 04 February 2023
Abstract:
The current work was conducted for isolation and identification of Proteus mirabilis from humans and cats. A total of one hundred and fifty samples were collected from hospitals of wasit city during the period from 23/7/2021 to 13/1/2022. These clinical samples included: (90) wound swabs from humans While the total number of samples amount to wound swabs in cats (60). These samples of humans were collected from Al- Zahra Teaching Hospital in wasit and the samples of cats is collected from different places. All isolates Proteus mirabilis were characterized according to the morphology and microscopic characteristics, along with the biochemical and confirmatory APi 20 E tests. These isolates were obtained from: humans (15) and cats (11).Then determination of antibiotics susceptibility pattern of recovered isolates. The human isolates showed resistant 100 % to Ampicillin, Penicillin, Trimethoprim-Sulfamethoxazole, Streptomycin, Chloramphenicol, Amoxicillin / clavulanic acid, Erythromycin, Tetracycline, Cefoxitin and Vancomycin. Sensitive (100%) for Gentamycin and Ofloxacin. otherwise the cat’s isolates showed resistant (100%) to Ampicillin, Penicillin, Trimethoprim-Sulfamethoxazole, Streptomycin, Chloramphenicol, Amoxicillin / clavulanic acid, Erythromycin, Tetracycline, Ofloxacin, Cefoxitin and Vancomycin. Sensitive (100%) for Gentamycin only.
Keywords:
Proteus mirabilis; Human; Cat; Api20E; Antibiotics
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0